🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research study is to learn about the effectiveness of u...
Status
Completed
Location
Penrose Cancer Center
Start Date
2012-02-07
Trial ID
NCT01530997
Treatments Being Tested
The optimal treatment for HRPC patients has not yet been established. Recen...
Status
Terminated
Location
Netherlands Cancer Institute
Start Date
2016-09
Trial ID
NCT03066154
Accelerated Partial Breast Irradiation by Mammosite and intensity modulated...
Status
Unknown
Location
Rocky Mountain Cancer Centers - Aurora
Start Date
2004-02
Trial ID
NCT01185145
Treatments Being Tested
This phase II trial compares the impact of brentuximab vedotin and nivoluma...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-04
Trial ID
NCT07572123
Treatments Being Tested
This will be the first study to assess the clinical feasibility of dose esc...
Status
Completed
Location
Saint Bartholomew's Hospital
Start Date
2010-07
Trial ID
NCT01230996
Treatments Being Tested
This is a non-randomized, phase II, open label study of postoperative concu...
Status
Completed
Location
Shanghai ninth people's hospital
Start Date
2016-03
Trial ID
NCT02776137
Treatments Being Tested
This clinical trial will evaluate a new combination of pembrolizumab, HPV-1...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2020-07-06
Trial ID
NCT04369937
Treatments Being Tested
This randomized phase II trial studies how well high or standard intensity ...
Status
Terminated
Location
Kaiser Permanente Oakland-Broadway
Start Date
2013-08
Trial ID
NCT01921751
This study will evaluate the safety of adding nivolumab to several chemothe...
Status
Completed
Location
Stanford Cancer Institute
Start Date
2016-06
Trial ID
NCT02764593
This study is designed to test the ability to achieve donor hematopoietic e...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2012-07-11
Trial ID
NCT01626092